Dominique Monnet
2018
In 2018, Dominique Monnet earned a total compensation of $2.5M as President and Chief Executive Officer at PDL BioPharma, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $346,500 |
|---|---|
| Option Awards | $1,568,740 |
| Salary | $525,000 |
| Other | $58,000 |
| Total | $2,498,240 |
Monnet received $1.6M in option awards, accounting for 63% of the total pay in 2018.
Monnet also received $346.5K in non-equity incentive plan, $525K in salary and $58K in other compensation.
Rankings
In 2018, Dominique Monnet's compensation ranked 4,675th out of 14,244 executives tracked by ExecPay. In other words, Monnet earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,675 out of 14,244 | 67th |
Division Manufacturing | 1,758 out of 5,765 | 70th |
Major group Chemicals And Allied Products | 635 out of 2,128 | 70th |
Industry group Drugs | 533 out of 1,817 | 71st |
Industry Biological Products, Except Diagnostic Substances | 106 out of 339 | 69th |
Source: SEC filing on April 30, 2019.
Monnet's colleagues
We found four more compensation records of executives who worked with Dominique Monnet at PDL BioPharma in 2018.